Research Main
¿¬±¸½Ç¼Ò°³
±³¼ö´Ô¼Ò°³
Publication
¿¬±¸½Ç¿ø¼Ò°³
°ü·Ã ÇÐȸ ÀÏÁ¤
Journal Club
¹«·á À̸ÞÀÏ @cell-signaling °èÁ¤ ¸¸µé±â

Designed
    by Heidi-Dream

 

´ë»çÁõÈıº ¹× ¼¼Æ÷ ½ÅÈ£Àü´Þ ¿¬±¸½Ç
(Matabolic Syndrome and Cell Signaling Laboratory)

 

 

¡á  Home > Publication

Int J Mol Med. (2014) May, 33(5), 1364-70. (IF=2.088)
 cell  09-06
Piao L, Park J, Li Y, Shin S, Shin S, Kong G, Shrestha R, Tran Q, Hur GM, Kim JL, Park J (2014) SOCS3 and SOCS6 are required for the risperidone-mediated inhibition of insulin and leptin signaling in neuroblastoma cells, Int J Mol Med., 2014 May;33(5):1364-70 (IF=2.088)
 PREV £º   Diabetologia. (2014) Dec;57(12):2576-85 (IF=6.487) cell 
 NEXT £º   Cellular Signaling (2014) Feb, 26, 295-305 (IF=4.304) cell 
 LIST   
Copyright 1999-2025 Zeroboard / skin by GGAMBO

 

 


Matabolic Syndrome and Cell Signaling Laboratory in Institute for Cancer Research
Department of Pharmacology, College of Medicine, Chungnam National University
266 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea
Tel: +82-42-280-6768 Fax: +82-42-585-6627
COPYRIGHT ¨Ï 2009 Metabolic Syndrome and Cell Signaling Laboratory, ALL RIGHTS RESERVED.